Testicular Cancer Guidelines.
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Le..., J Natl Compr Canc Netw 10:502-35Treatment of Metastatic Prostate Cancer – How Urologists should Sequence Available Agents.
Mostaghel EA and Lin DW, AUA Update SeriesIs Pre-diagnosis PSA Velocity Predictive of the Risk of Death from Prostate Cancer Following Radical Prostatectomy?
Lin DW and Lange PH, Nature Clinical Practice Urology 1: 66Re: Prostate-specific Antigen Velocity in Men with Total Prostate-Specific Antigen Levels Less Than 4ng/ml.
Lin DW, Journal of Urology 178: 2352-3Re: Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
Lin DW, Urologic Oncology 25: 529Re: Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.
Lin DW, Urologic Oncology 25: 527-8Re: EPCA-2: A highly specific serum marker for prostate cancer.
Lin DW, Urologic Oncology 25: 528Re:Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
Lin DW, Urologic Oncology 25: 528-9Re: Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy.
Lin DW, Eur Urology 53: 345-6Re: Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.
Lin DW, Urologic Oncology 26: 680-1Re: Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.
Lin DW, Urologic Oncology 26: 681-2Re: Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after prostatectomy.
Lin DW, Urologic Oncology 26: 682-3Re: Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
Lin DW, Journal of UrologyRe: Adjuvant radiotherapy for patients with locally advanced prostate cancer – a new standard?
Lin DW, Urologic OncologyRe: Primary Retroperitoneal Lymph Node Dissection in Patients With Clinical Stage IS Testis Cancer.
Lin DW, Journal of Urology 182:2720Prostate cancer risk stratification by genotype and PSA.
Wright JL and Lin DW, Nature Reviews Urology 6:641-2Re: Mortality results from a randomized prostate-cancer screening trial: Andriole GL, Crawford ED, Grubb RL III, et al.
Lin DW, Urologic Oncology 27: 688-9Re: Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conven...
Lin DW, Urologic Oncology 27: 689-90Re: Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer: Attard G, Reid AH, A'Hern R, et al.
Lin DW, Urologic Oncology 27: 690-1Re: Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?: Tareen B, Godoy G, Sankin A, et al.
Lin DW, Urologic Oncology 27: 691Re: Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer: Morris MJ, Huang D, Kelly WK, et al.
Lin DW, Urologic Oncology 27: 692Value of Urethral Wash after Radical Cystectomy.
Lin DW, Herr HW, Dalbagni G, Journal of Urology 165 (5 suppl): 715APhenotypic Heterogeneity in Disseminated Prostate Cancer Tumor Cells: Implications in Epithelial to Mesenchymal Transition.
Koreckij TD, Morgan TM, Lange PH, Coleman I, Coleman R, Ellis WJ, Lin DW, Montgomery B, Lakely B, Morrissey C, and Vessella RL, Journal of Urology 181 (4 suppl): 2086AThe Effect of Sequential Compression Devices on Intraoperative Blood Loss During Radical Prostatectomy.
Koch MO, Brandell RA, Lin D, Smith JA, Journal of Urology 152: 1178-9Transition Zone PSA Density: Lack of Utility in Prediction of Prostatic Carcinoma.
Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK, Journal of Urology 160: 77-82- Join now to see all